A T cell receptor targeting a recurrent driver mutation in FLT3 mediates elimination of primary human acute myeloid leukemia in vivo
2023 · Nature Cancer · 34 citations
https://doi.org/10.1038/s43018-023-00642-8
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
9
Papers
123
Citations
5
h-index
4
i10-index
Madeleine Lehander is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Mesenchymal stem cell research & Acute Myeloid Leukemia Research. The author has an h-index of 5, co-authored 8 publications.
ORCID: 0009-0005-0114-4502https://doi.org/10.1038/s43018-023-00642-8
https://doi.org/10.64898/2026.02.17.706359
Click to start Chat